New Insight on Adipose Tissue Function in Advanced Renal Failure
DOI:
https://doi.org/10.17140/OROJ-2-e002Keywords:
sophisticated, adipocytokinesAbstract
Adipose tissue has been considered simply as an exclusive fat storage organ for a
long period. Later in the mid-1990s and after identification of leptin, a revolution occurred in
understanding of white adipose tissue function. In fact, adipose tissue has been recognized as
a dynamic endocrine organ, which could affect whole body homeostasis.1
Thereafter, more
than 50 secretory peptides, which are called “adipokines” or “adipocytokines”, with diverse
metabolic functions have been identified2
and the biological role of adipose tissue became more
sophisticated and interesting.
The adipokines may act through an autocrine, paracrine and endocrine manner. They
are supposed to be involved in a wide range of physiologic to pathologic processes including
dietary intake and appetite regulation, energy expenditure, insulin resistance, lipid metabolism,
immunity, inflammation and acute-phase responses, vascular homeostasis, endothelial function, angiogenesis and so on.2,3Leptin, adiponectin, ghrelin, resistin, visfatin, vaspin, omentin,
TNF-α, and IL-6 are among the most studied adipokines in health and disease. However, studies regarding the extensive biological and metabolic functions of adipokines are still ongoing.
References
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994; 372: 425-432. doi: 10.1038/372425a0
Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004; 92: 347-355. doi: 10.1079/BJN20041213
Lago F, Dieguez C, Gomez-Reino J, Gualillo O. The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev. 2007; 18: 313-325. doi: 10.1016/j.cytogfr.2007.04.007
Ruster C, Wolf G. Adipokines promote chronic kidney disease. Nephrol Dial Transplant. 2013; 28(Suppl 4): iv8-14. doi: 10.1093/ ndt/gft191
Ohashi K, Shibata R, Murohara T, Ouchi N. Role of anti-inflammatory adipokines in obesity-related diseases. Trends in endocri-nology and metabolism: TEM. 2014; 25: 348-355. doi: 10.1016/j.tem.2014.03.009
Briffa JF, McAinch AJ, Poronnik P, Hryciw DH. Adipokines as a link between obesity and chronic kidney disease. Am J Physiol Renal Physiol. 2013; 305: F1629-F1636. doi: 10.1152/ajprenal.00263.2013
Briffa JF, Grinfeld E, McAinch AJ, Poronnik P, Hryciw DH. Short term exposure to elevated levels of leptin reduces proximal tubule cell metabolic activity. Mol Cell Endocrinol. 2014; 382: 38-45. doi: 10.1016/j.mce.2013.09.001
Iglesias P, Diez JJ. Adipose tissue in renal disease: clinical significance and prognostic implications. Nephrol Dial Transplant. 2010; 25: 2066-2077. doi: 10.1093/ndt/gfq246
Axelsson J, Stenvinkel P. Role of fat mass and adipokines in chronic kidney disease. Curr Opin Nephrol Hypertens. 2008; 17: 25-31.
Jia T, Carrero JJ, Lindholm B, Stenvinkel P. The complex role of adiponectin in chronic kidney disease. Biochimie. 2012; 94: 2150-2156. doi: 10.1016/j.biochi.2012.02.024
Menon V, Li L, Wang X, et al. Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol. 2006; 17: 2599-2606. doi: 10.1681/ASN.2006040331
Jorsal A, Tarnow L, Frystyk J, et al. Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy. Kidney Int. 2008; 74: 649-654. doi: 10.1038/ki.2008.201
Russell ST, Tisdale MJ. Antidiabetic properties of zinc-alpha2-glycoprotein in ob/ob mice. Endocrinology. 2010; 151: 948-957. doi: 10.1210/en.2009-0827
Mracek T, Ding Q, Tzanavari T, et al. The adipokine zinc-alpha2-glycoprotein (ZAG) is downregulated with fat mass expansion in obesity. Clin Endocrinol (Oxf). 2010; 72: 334-341. doi: 10.1111/j.1365-2265.2009.03658.x
Ceperuelo-Mallafre V, Naf S, Escote X, et al. Circulating and adipose tissue gene expression of zinc-alpha2-glycoprotein in obesity: its relationship with adipokine and lipolytic gene markers in subcutaneous and visceral fat. J Clin Endocrinol Metab. 2009; 94: 5062-5069. doi: 10.1210/jc.2009-0764
Eckardt K, Schober A, Platzbecker B, et al. The adipokine zinc-alpha2-glycoprotein activates AMP kinase in human primary skeletal muscle cells. Arch Physiol Biochem. 2011; 117: 88-93. doi: 10.3109/13813455.2011.560950
Bing C, Russell ST, Beckett EE, et al. Expression of uncoupling proteins-1, -2 and -3 mRNA is induced by an adenocarcinoma-derived lipid-mobilizing factor. Br J Cancer. 2002; 86: 612-618.
Gao D, Trayhurn P, Bing C. Macrophage-secreted factors inhibit ZAG expression and secretion by human adipocytes. Mol Cell Endocrinol. 2010; 325: 135-142. doi: 10.1016/j.mce.2010.05.020
Selva DM, Lecube A, Hernandez C, Baena JA, Fort JM, Simo R. Lower zinc-alpha2-glycoprotein production by adipose tissue and liver in obese patients unrelated to insulin resistance. J Clin Endocrinol Metab. 2009; 94: 4499-4507. doi: 10.1210/jc.2009-0758
Hirai K, Hussey HJ, Barber MD, Price SA, Tisdale MJ. Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients. Cancer Res. 1998; 58: 2359-2365.
Todorov PT, McDevitt TM, Meyer DJ, Ueyama H, Ohkubo I, Tisdale MJ. Purification and characterization of a tumor lipid-mobilizing factor. Cancer Res. 1998; 58: 2353-2358.
Philipp A, Kralisch S, Bachmann A, et al. Serum levels of the adipokine zinc-alpha2-glycoprotein are increased in chronic he-modialysis. Metabolism. 2011; 60: 669-672. doi: 10.1016/j.metabol.2010.06.019
Leal VO, Lobo JC, Stockler-Pinto MB, et al. Zinc-alpha2-glycoprotein: is there association between this new adipokine and body composition in hemodialysis patients? Ren Fail. 2012; 34: 1062-1067. doi: 10.3109/0886022X.2012.712859
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Obesity Research (OR) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.